{
  "id": 5370991,
  "title": "Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer",
  "url": "https://urgent.news/2026/09/03/groundbreaking-pancreatic-cancer-drug-shows-promise-in-lung-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-03T16:58:08.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/lungcancer/122876"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The landmark oral RAS inhibitor daraxonrasib (Rasonque) showed efficacy in previously treated patients with metastatic RAS-mutant non-small cell lung cancer (NSCLC) in a phase I/II trial. Among 136 patients treated with daraxonrasib...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "ABC News (US)",
        "title": "Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests",
        "url": "https://urgent.news/2026/09/03/pancreatic-cancer-drug-may-hold-promise-for-lung-cancer-as-well-early",
        "published": "2026-09-03T15:13:21.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}